Literature DB >> 4013826

Does fever or myalgia indicate reduced physical performance capacity in viral infections?

G Friman, J E Wright, N G Ilbäck, W R Beisel, J D White, D S Sharp, E L Stephen, W L Daniels, J A Vogel.   

Abstract

To study prospectively the effects of a brief febrile viral infection on parameters of muscle and circulatory function, seven volunteers were inoculated with sandfly fever virus and two control subjects with sterile saline. During but not after fever, decreased isometric and dynamic strength and endurance were recorded in various muscles. Impairment could not be explained by altered activities of relevant muscle enzymes in serum or muscle tissue or by altered muscle ultrastructure, but correlated with the severity of perceived symptoms, including myalgia, as rated by each subject. Compared to baseline, cardiac stroke volume was lower during and after fever. During fever, an increased heart rate maintained cardiac output at pre-inoculation values, whereas cardiac output fell in early convalescence. This decrease in cardiac output correlated significantly with the severity of fever. Thus, in brief viral infections a transient impairment of muscle performance capacity is correlated to subjective symptoms such as myalgia, rather than to fever, whereas a decreased cardiac output following such infections seems to be associated with the fever reaction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4013826     DOI: 10.1111/j.0954-6820.1985.tb02709.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  10 in total

1.  Critical diaphragm failure in sudden infant death syndrome.

Authors:  Pontus Max Axel Siren; Matti Juhani Siren
Journal:  Ups J Med Sci       Date:  2011-01-12       Impact factor: 2.384

2.  Human quadriceps strength and fatiguability in patients with post viral fatigue.

Authors:  O M Rutherford; P D White
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

3.  Fever after acute myocardial infarction in patients treated with intravenous timolol or placebo.

Authors:  C Risøe; O J Kirkeby; P Grøttum; M Sederholm; J K Kjekshus
Journal:  Br Heart J       Date:  1987-01

Review 4.  Infectious disease in athletes.

Authors:  T L Sevier
Journal:  Med Clin North Am       Date:  1994-03       Impact factor: 5.456

5.  Virus infections and sports performance--a prospective study.

Authors:  J A Roberts; J A Wilson; G B Clements
Journal:  Br J Sports Med       Date:  1988-12       Impact factor: 13.800

6.  Sport, exercise, and the common cold.

Authors:  T G Weidner; T L Sevier
Journal:  J Athl Train       Date:  1996-04       Impact factor: 2.860

7.  Febrile illness in the athlete.

Authors:  Natalie A Dick; Jason J Diehl
Journal:  Sports Health       Date:  2014-05       Impact factor: 3.843

Review 8.  Special feature for the Olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes.

Authors:  G Friman; L Wesslén
Journal:  Immunol Cell Biol       Date:  2000-10       Impact factor: 5.126

Review 9.  Viral illnesses and sports performance.

Authors:  J A Roberts
Journal:  Sports Med       Date:  1986 Jul-Aug       Impact factor: 11.136

Review 10.  Infection in athletes.

Authors:  I K Brenner; P N Shek; R J Shephard
Journal:  Sports Med       Date:  1994-02       Impact factor: 11.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.